
Sign up to save your podcasts
Or


In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.
C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.
By Chemical & Engineering News4.8
7070 ratings
In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.
C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.

90,855 Listeners

22,008 Listeners

44,011 Listeners

32,305 Listeners

38,778 Listeners

26,247 Listeners

767 Listeners

12,129 Listeners

827 Listeners

6,467 Listeners

16,461 Listeners

6,580 Listeners

2,313 Listeners

1,375 Listeners

18 Listeners